United States · FDA National Drug Code directory
Ondansetron
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71335-2973_0d752116-b9e4-4ee6-a395-0e4a83f892dc
- Product NDC
- 71335-2973
- Form
- TABLET, ORALLY DISINTEGRATING
- Composition / generic term
- Ondansetron
- Labeler
- Bryant Ranch Prepack
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250619
- Source listing expiry
- 20261231
Source-listed ingredients
- ONDANSETRON — 8 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 90 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-2973-1) · 71335-2973-1
- 60 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-2973-2) · 71335-2973-2
- 30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-2973-3) · 71335-2973-3
- 14 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-2973-4) · 71335-2973-4
- 12 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-2973-5) · 71335-2973-5
- 10 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-2973-6) · 71335-2973-6
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →